In colon and osteosarcoma cell lines, MTHFD2 has been identified as a transcriptional target of p53, although its depletion can also activate p53 and its target p21 via AMPK signaling stimulation caused by the accumulation of the metabolic intermediate AICAR73. The gene discussed is TP53; the disease is osteosarcoma.